Morphologic features of polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-11001725

Enrollment

Unknown

Registered

2011-11-21

Start date

2011-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polypoidal choroidal vasculopathy

Interventions

1:choroid

2:choroid

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: serous retinal detachment without blood or deposit in macular,one or a few leaks on FFA, and branching vascular network or polypoidal hyperfluorescence on ICGA, focal retinal detachment on OCT, personal consent form signed

Exclusion criteria

Exclusion criteria: Eyes were excluded if subretinal hemorrhage or orange-red nodules or lipids were present and if there was a history of previous photodynamic therapy or laser photocoagulation or if additional diagnoses that could compromise visual acuity were present

Design outcomes

Primary

Measure	Time frame
choroid;	—

Countries

China

Contacts

Public ContactWei Wenbin

Trweiwenbin@yahoo.com.cn+86 13701255115

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026